© Foto: picture alliance / ASSOCIATED PRESS | Mark Lennihan
Realtime | Geld | Brief | Zeit |
---|---|---|---|
116,96 | 117,22 | 26.07. | |
116,50 | 116,84 | 26.07. |
© Foto: picture alliance / ASSOCIATED PRESS | Mark Lennihan
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Fr | Chasing Pfizer and Lilly, Sun Pharma wins FDA nod for alopecia areata med Leqselvi | ||
Fr | Is Eli Lilly Stock A Sell On A Second Stumble In Obesity Treatment? | ||
Fr | Prediction: This Is What Eli Lilly Stock Will Do Next | ||
Fr | Watch These Eli Lilly Stock Price Levels as Weight-Loss Drug Competition Rises | ||
Fr | Is Eli Lilly Stock Headed Toward $1300 Levels? |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Fr | Novo Nordisk Unusual Options Activity For July 26 | ||
Fr | FDA issues warning on compounded versions of Novo Nordisk's semaglutide | ||
Fr | EMA backs Wegovy cardiovascular label update as Novo seeks EU coverage | ||
Fr | US FDA warns of dosing errors with compounded versions of Novo's weight loss drugs | ||
Fr | Europe Approves Novo Nordisk's Weight Loss Drug To Treat Heart Ailments |
Unternehmen / Aktien | Kurs | % |
---|---|---|
ELI LILLY AND COMPANY | 738,30 | -0,43 % |
NOVO NORDISK A/S | 116,52 | -0,14 % |